Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LKB1 loss links the serine metabolic network to DNA methylation and tumourigenesis

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE86145 | GEO | 2016/10/24

SECONDARY ACCESSION(S): PRJNA340375

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

LKB1 loss links the serine metabolic network to DNA methylation and tumourigenesis [bisulfite-seq]

Project description:Intermediary metabolism generates substrates for covalent modification of chromatin, enabling potential coupling of metabolic states and epigenetic control. Here, we identify such a network as a major component of oncogenic transformation downstream of the LKB1 tumour suppressor. LKB1 encodes a serine-threonine kinase that integrates nutrient availability, metabolism and growth, however the mechanisms for LKB1-dependent tumour suppression remain elusive. By developing genetically engineered mouse and primary epithelial cell models and employing transcriptional, proteomics, and metabolic analyses, we find that oncogenic cooperation between LKB1 loss and KRAS activation, alterations commonly coinciding in human cancer, is fueled by pronounced mTOR-dependent induction of the serine-glycine-one carbon network coupled to S-adenosylmethionine generation. In concert, DNA methyltransferases (DNMT1, DNMT3A) are upregulated, leading to elevation in genomic 5-methylcytosine levels, with particular enrichment at retrotransposon elements, associated with silencing of retrotransposon transcription. Correspondingly, LKB1 deficiency renders cells highly sensitive to inhibition of serine biosynthesis and DNA methylation in vitro and in vivo. Thus, we define a hypermetabolic state resulting from LKB1 loss and KRAS activation that fuels changes in the epigenetic landscape. This state is critically required for the tumourigenic program of LKB1-mutant cells, suggesting novel points of therapeutic intervention in defined patient subsets.

2016-10-24 | GSE86143 | GEO

LKB1 loss links the serine metabolic network to DNA methylation and tumourigenesis [RNA-seq]

2016-10-24 | GSE86144 | GEO

LKB1 loss links the serine metabolic network to DNA methylation and tumourigenesis

Project description:LKB1 loss links the serine metabolic network to DNA methylation and tumourigenesis

| PRJNA340375 | ENA

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis.

Project description: Not available

| S-EPMC5988435 | biostudies-literature

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

Project description:Proteome maps were generated for pancreatic ductal epithelial cells from LSL KRASG12D/+ and LSL KRASG12D/+;LKB1l/l mice. The cells were isolated from the mice, and genetic lesions were induced in vitro by infection with Ade-Cre. Proteome maps were done with multiplexed proteomics using TMT10plex technology. Mass spectrometry was done on an Orbitrap Fusion using the SPS-MS3 method. Samples were TMT labeled as follows: K1-1 (126), K1-2 (129n), K2-1 (127n), K2-2 (129c), KL1-1 (127c), KL1-2 (130n), KL2-1 (128n), KL2-2 (130c).

2018-03-20 | MSV000082186 | MassIVE

Resistance to serine in Bacillus subtilis: identification of the serine transporter YbeC and of a metabolic network that links serine and threonine metabolism.

Project description: Not available

| S-EPMC8226366 | biostudies-literature

MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.

Project description: Not available

| S-EPMC8040069 | biostudies-literature

Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.

Project description: Not available

| S-EPMC3932920 | biostudies-literature

Characterization of the usage of the serine metabolic network in human cancer.

Project description: Not available